tradingkey.logo

Myomo Inc

MYO
查看详细走势图
0.803USD
+0.030+3.88%
收盘 02/06, 16:00美东报价延迟15分钟
30.87M总市值
亏损市盈率 TTM

Myomo Inc

0.803
+0.030+3.88%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.88%

5天

-4.29%

1月

-21.26%

6月

-56.59%

今年开始到现在

-11.75%

1年

-87.15%

查看详细走势图

TradingKey Myomo Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Myomo Inc当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名85/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价5.00。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Myomo Inc评分

相关信息

行业排名
85 / 205
全市场排名
233 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Myomo Inc亮点

亮点风险
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
业绩高增长
公司营业收入稳步增长,连续3年增长109.26%
业绩增长期
公司处于发展阶段,最新年度总收入32.55M美元
估值高估
公司最新PE估值-2.80,处于3年历史高位
机构减仓
最新机构持股21.70M股,环比减少16.85%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值1.56M
活跃度增加
近期活跃度增加,过去20天平均换手率2.52

分析师目标

根据 5 位分析师
买入
评级
5.000
目标均价
+546.75%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Myomo Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Myomo Inc简介

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
公司代码MYO
公司Myomo Inc
CEOGudonis (Paul R)
网址https://myomo.com/
KeyAI